Consumer Driven Health Care

Finding innovative ways to get a handle on pharmaceutical spending is a top priority for employers.

Cost may be a major issue limiting adoption of gene therapy, but it's not the only one.

That equates to an estimated $760 billion to $935 billion every year in wasteful health care spending.

Morningstar study of youthful HSA industry finds some funds still costly, some investment menus still cluttered, and some fail basic transparency standards.

How marketing with non-insurance alternatives can address common concerns and increase enrollment.

Would-be innovators of digital health tools face a variety of challenges in the health care space.